Evidence map›Paper›PMID 33343028›Full record

ArticleThe journal of extra-corporeal technology2020

Tracheostomy while on Extracorporeal Membrane Oxygenation: A Comparison of Percutaneous and Open Procedures.

Ismael A Salas De Armas, Kha Dinh, Bindu Akkanti, Pushan Jani, Reshma Hussain, Lisa Janowiak, Kayla Kutilek, Manish K Patel, Mehmet H Akay, Rahat Hussain and 6 more

Abstract read
In one paragraph

Article in The journal of extra-corporeal technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Academic Perfusion at Its Best and a New Tradition.The journal of extra-corporeal technology · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ismael A Salas De ArmasDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Kha DinhDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Bindu AkkantiDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pushan JaniDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Reshma HussainDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Lisa JanowiakDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Kayla KutilekDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Manish K PatelDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Mehmet H AkayDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Rahat HussainDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Jayeshkumar PatelDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Chandni PatelDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Yafen LiangDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
John ZakiDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Biswajit KarDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Igor D GregoricDepartment of Advanced Cardiopulmonary Therapies and Transplantation, Department of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas; and Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, Texas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the ideal timing of tracheostomy for critically ill patients is controversial, transitioning from an endotracheal tube can be beneficial. Concerns arise for patients under extracorporeal membrane oxygenation (ECMO) support. Studies have described percutaneous and open tracheostomy approaches for critically ill patients but, to our knowledge, have not compared the two specifically in ECMO patients. This study analyzed safety and aimed to identify if there was a difference in major bleeding or other tracheostomy-associated complications. A single-center retrospective cohort study of all patients who received tracheostomy while on ECMO from July 2013 to May 2019 was completed. The primary endpoint was a significant difference in the incidence of a major bleeding adverse event at 48 hours. Secondary endpoints included differences in the incidence of complications (e.g., procedure-related mortality, ECMO decannulation, tracheal/esophageal injury, and pneumothorax/pneumomediastinum) and survival to discharge. A secondary analysis separated the groups further by comparing those with bleeding events and those without. The study included 27 ECMO patients: 16 (59%) in the percutaneous arm and 11 in the open arm. The median number of ECMO days before tracheostomy was 10 vs. 13, respectively. There were no statistically significant differences between the two groups for major bleeding events (percutaneous 44% vs. open 27%,

Indexed as

Extracorporeal Membrane OxygenationTracheostomyHemorrhageHumansPostoperative ComplicationsRetrospective Studiesbleedingcomplicationsextracorporeal membrane oxygenationopen tracheostomypercutaneous tracheostomy

Identifiers

PMID33343028
PMCPMC7728494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.